(Q40779899)

23 September 2017

Implications of vancomycin-resistant Staphylococcus aureus (English)

1 reference

23 September 2017

Staphylococcus aureus

1 reference

Tenover FC

1

1 reference

23 September 2017

1 December 1999

1 reference

Journal of Hospital Infection

23 September 2017

1 reference

23 September 2017

43 Suppl

1 reference

23 September 2017

S3-7

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990060-9

23 September 2017

1 reference

7 January 2021

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990060-9

7 January 2021

First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990060-9

7 January 2021

Vancomycin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990060-9

7 January 2021

Vancomycin resistance in staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990060-9

7 January 2021

Definition of the Clinical Antibacterial Spectrum of Activity

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990060-9

7 January 2021

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990060-9

7 January 2021

Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990060-9

7 January 2021

Reduced susceptibility to teicoplanin in a methicillin-resistant strain of Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990060-9

7 January 2021

Methicillin-resistant Staphylococcus aureus nasal carriage and infections in CAPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990060-9

7 January 2021

Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990060-9

7 January 2021

Staphylococcus aureus carriage and infections among patients in four haemo- and peritoneal-dialysis centres in Denmark. The Danish Study Group of Peritonitis in Dialysis (DASPID).

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990060-9

7 January 2021

Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990060-9

7 January 2021

Trying to control MRSA causes more problems than it solves.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990060-9

7 January 2021

Control of an outbreak of an epidemic methicillin-resistant Staphylococcus aureus also resistant to mupirocin

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990060-9

7 January 2021

In vitro activities of two novel oxazolidinones (U100592 and U100766), a new fluoroquinolone (trovafloxacin), and dalfopristin-quinupristin against Staphylococcus aureus and Staphylococcus epidermidis

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2899%2990060-9

7 January 2021

10.1016/S0195-6701(99)90060-9

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

10658753